Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-802-8 | CAS number: 99-93-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: well documented GLP study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
- Principles of method if other than guideline:
- This study were operated/conducted in accordante with the requirements and recommendations of the Animal Welfare Act (P.L. 89-544 as amended by P.L. 91-579 and P.L. 94-279), and other applicable federal, state and local laws, regulations and policies.
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- testing lab.
- Limit test:
- yes
Test material
- Reference substance name:
- 4'-hydroxyacetophenone
- EC Number:
- 202-802-8
- EC Name:
- 4'-hydroxyacetophenone
- Cas Number:
- 99-93-4
- Molecular formula:
- C8H8O2
- IUPAC Name:
- 1-(4-hydroxyphenyl)ethan-1-one
- Details on test material:
- Name of the test substance used in the study report: C-800
white clumped powder; 99.7% active ingredient
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Age at initiation of exposure (approx.): 7 weeks
Weight at initiation of exposure: 260 - 303 g
Animals were acclimated for 2 weeks. All animals were examined by the staff veterinarian during the acclimation period.
Each rat was identified with a metal ear tag bearing its unique Bio/dynamics, Inc. animal number. If the tag was lost, it was replaced. In addition, each cage was provided with a cage card which was color-coded for dose level identification and contained the project number, animal number, sex and exposure group information.
Husbandry during non-exposure periods: The animals were doubly housed in stainless steel wire mesh cages during the 1st week of the acclimation period and individually housed thereafter. A standardized laboratory animal diet as well as drinking water were offered ad libitum.
The day/night rhythm was 12 h dark and 12 h light. Room temperature 19 - 26°C, relative humidity: 29 - 70%.
Husbandy during exposurep eriods: The animals were individually housed in stainless steel, wire mesh cages within a 1000 liter glass and stainless steel exposure chamber. Food and drinkg water were not available. Room temperature 29 - 28°C, relative humidity: 10 - 70%.
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- clean air
- Details on inhalation exposure:
- Exposure level was determined gravimetrically or spectrophotometrically and particle size distribution measurements (average mass median aerodynamic diameter, (MMAD)) were made in regular intervals throughout the study.
- Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- 28 d
- Frequency of treatment:
- 6 h/d, 5 d/w
Doses / concentrations
- Remarks:
- Doses / Concentrations:
42 mg/m3
Basis:
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent no treatment
Examinations
- Observations and examinations performed and frequency:
- The animals were observed for clinical findings of intoxication, detailed physical examinations were conducted weekly, body weight was determined weekly, hematology measurements were performed an all animals at week 4 and clinical chemistry (serum GPT, alkaline phophatase, albumin, total bilirubin, gamma glutamyl transpeptidase) was performed at week 1 (5 animals/group) and at week 4 on all animals.
- Sacrifice and pathology:
- After 4 weeks of exposure all animals were sacrificed, selected organs (brain, kidneys, liver, lungs, testes, spleen) were weighed and relative (in relation to the brain) organ weights were calculated, complete gross postmortem examinations and histological examination after hematoxylin and eosin staining of selected tissues (kidneys, liver, lungs, spleen, testes/epididymides) were conducted an all animals.
Results and discussion
Results of examinations
- Details on results:
- Particle size distribution measurements for the test substance revealed an MMAD of 11 u with a geometric standard deviation of 2.0. Over 48% of particles were found to be 10 u or less, indicating that the test atmosphere was only moderately respirable in size.
The only significant deviation observed was a significant decrease of albumin after the first week of exposure. After 4 weeks the albumin values had returned to normal values. This finding was considered of unclear toxicological significance.
Effect levels
- Dose descriptor:
- NOAEC
- Effect level:
- 42 mg/m³ air
- Based on:
- act. ingr.
- Sex:
- male
- Basis for effect level:
- other: overall effects
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Dust exposure of 42 mg/m3 of the test substance did not lead to mortality nor to any other treatment-related findings after 28 days of exposure. Thus, this dose level can be considered as a no observed effect level (NOEL) under the conditions of the present investigation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.